Ginkgo Bioworks
Ginkgo Bioworks is a leading synthetic biology company that partners with organizations across various industries to harness the power of biology. Their mission is to make biology easier to engineer, enabling the development of innovative solutions in agriculture, biopharma, industrial biotechnology, and more. Ginkgo's platform combines advanced automation, data analytics, and a vast library of genetic assets to accelerate research and development, optimize production processes, and reduce costs. They are revolutionizing industrial processes with biological solutions that lower costs, open new markets, valorize waste streams, and create sustainable supply chains.
Ginkgo Bioworks
27 Drydock Avenue, 8th Floor, Boston, MA 02210
What We Do
Ginkgo Bioworks offers comprehensive R&D services across multiple sectors, including agriculture, biopharma, industrial biotechnology, and more. Their services include strain optimization, fermentation process development, and lab-to-field testing.
Design a multi-layered biosecurity program to protect the things you care about the most.
Scale up your fermentation from 250 mL to >50,000 L on our platform.
Screen millions of strain variants to optimize for your application.
Engineer and optimize biosynthetic pathways for small molecules.
Discover and optimize the production of novel proteins for a variety of applications.
Discover, engineer, optimize, and scale up enzymes for your application.
Ginkgo offers seamless end-to-end solutions for lab automation, combining robust hardware and software with dedicated support to offer scalable, efficient, and cost-effective workflows.
Ginkgo provides end-to-end support for RNA therapeutics developers, from early discovery to proof-of-concept animal studies, enabling the development of RNA drugs in various formats.
Optimize your payload, delivery, and production with end-to-end solutions for gene therapies, including capsid and payload engineering.
Ginkgo offers capabilities to support discovery efforts for all cell-based therapies, including CAR-T and iPSC-derived therapies, with a focus on genetic engineering and process optimization.
Ginkgo supports enzyme R&D projects across all stages, from discovery to manufacturing, using AI-guided design and high-throughput automation.
Ginkgo offers biologics discovery and engineering services, leveraging synthetic biology to develop novel biologics for therapeutic applications.
Engineer and optimize biosynthetic pathways for natural products, leveraging Ginkgo’s expertise in metabolic engineering and foundry scale to program microorganisms for molecule production.
Access Ginkgo’s fermentation capacity, ranging from small scale to 50,000 L with manufacturing partners, to develop fermentation processes that transfer to commercial scale.
Utilize Ginkgo’s thermal, physical, and chemical separation capabilities to purify samples for further analysis, testing, or proof of concept.
Receive analytical quality support and project scoping from Ginkgo’s QC team, ensuring accurate and reproducible results throughout your project.
Access pilot scale production with microbial fermentation capabilities at 20, 300, and 3,000 L scales, using various purification techniques.
Receive cost modeling and feasibility assessments, along with comprehensive project engineering support for contracts, procurement, and tech transfer.
A platform for AI model training and research, focusing on data generation and application in synthetic biology.
A data generation platform for AI model training, launched to enhance AI capabilities in synthetic biology.
Pre-characterized candidate strains to accelerate discovery and development in ag biologicals.
Modular hardware building blocks that allow for (re)assembly of work cells within days or hours, not months.
A protein sequence LLM trained on 2 billion proprietary sequences, designed to enhance protein engineering tasks.
A project focused on genome engineering to produce specialty chemicals efficiently.
Projects aimed at improving proteins, enzymes, fats, oils, flavors, and fragrances in the nutrition and wellness sector.
Key People
Co-Founder & CEO
AI Researcher
AI Developer
AI Developer
Co-Founder & President
Co-Founder
News & Updates
Ginkgo Bioworks announced the launch of Ginkgo Datapoints, a platform for generating data to train AI models, enhancing their capabilities in synthetic biology.
Ginkgo Bioworks introduced their Model API, a tool for AI research and development in synthetic biology.
Ginkgo Bioworks is leveraging big data and AI to revolutionize enzyme engineering, enhancing the efficiency and specificity of enzyme design.
Ginkgo Bioworks announced the opening of Bioworks7, expanding their capacity in biopharmaceuticals, biomanufacturing, and mammalian programming for therapeutic applications.
Ginkgo Bioworks acquired Altar and Circularis to enhance capabilities in adaptive laboratory evolution, circular RNA, and promoter screening.
Ginkgo Bioworks helped a partner reduce the amount of exogenous enzyme needed in their manufacturing process by ten-fold, saving millions in input costs through enzyme discovery services.